We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ariosa Can't Shake $27M Verdict In Illumina Prenatal IP Row

Law360 (July 20, 2018, 6:02 PM EDT) -- A California federal judge on Thursday refused to toss a $27 million verdict against Roche unit Ariosa Diagnostics Inc. for infringing Illumina Inc.'s patents for at-home prenatal testing technology, but allowed Ariosa to continue selling two versions of its tests.

U.S. District Judge Susan Illston rejected Ariosa's arguments that its supply agreement with Illumina-predecessor Verinata Health Inc. didn't grant it express license over the testing technology, that Illumina breached the agreement by suing and that the two patents were invalid. But the judge also denied Illumina's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.